Key facts
- This page summarizes Maria-Luisa Maccecchini's Form 4 filing for Annovis Bio, Inc. (ANVS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2025, 09:19.
Maria-Luisa Maccecchini - 28 Oct 2025 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- ANVS
- Reported as of
- 28 Oct 2025
- Net transaction value
- +$200,000
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2025, 09:19:04 UTC
- Prior SEC filing
- 05 Jun 2025
- Next SEC filing
- 13 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maria Maccecchini
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Maria-Luisa Maccecchini filed Form 4 for Annovis Bio, Inc. (ANVS) on 12 Nov 2025.
Change
- Previous filing in this sequence was filed on 05 Jun 2025.
- Current net transaction value: +$200,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001315018
Primary reporting owner
Maccecchini Maria-Luisa
- Relationship
- President & CEO, Director
- Address
- C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR, SUITE 225, MALVERN
- Signature
- /s/ Maria Maccecchini
- Signature date
- 12 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANVS
transaction
Common Stock
Purchase
- Transaction value
- $200,000
- Shares
- +97,561
- Change %
- +8.8%
- Price
- $2.05
- Shares after
- 1,212,020
- Date
- 28 Oct 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.